Jeanette Tetrault, MD, FACP, FASAM

Dr. Tetrault is an Associate Professor of Medicine and a clinician educator in the Section of General Internal Medicine at Yale School of Medicine. She is the Program Director for the Yale Addiction Medicine Fellowship. She is a primary care physician and addiction medicine specialist at the APT Foundation, which is a large, open access treatment program in New Haven CT which provides care to over 6,000 patients. There she provides primary care services and chronic disease management, including HIV and Hepatitis C treatment; assessment and ongoing treatment of alcohol, opioid and other substance use disorders; ambulatory detoxifications; and harm reduction services. She is co-director of the Addiction Recovery Clinic at Yale New Haven Hospital St. Raphael’s Campus Adult Primary Care Center, which is an addiction treatment clinic embedded within primary care practice which serves a dual clinical and educational mission for Yale residents and medical students. For the past 10 years, Dr. Tetrault has served as the Internal Medicine Team Leader for the Substance Abuse and Mental Health Services Administration-funded Screening, Brief Intervention and Referral to Treatment (SBIRT) initiative at Yale University School of Medicine. She is the president-elect of the American College of Academic Addiction Medicine. She is certified in addiction medicine through the American Board of Preventive Medicine, co-chair of the Society of General Internal Medicine’s (SGIM) Alcohol, Tobacco and Other Drug Use Interest Group, and past- president for the New England Region of SGIM. In June 2017, Dr. Tetrault was selected as a Macy Foundation Faculty Scholar to develop an interprofessional longitudinal addiction curriculum at Yale Schools of Medicine and Nursing. She was recognized by the Association of Medical Education and Research in Substance use and Addiction (AMERSA) with the W. Anderson Spickard Award for Excellence in Mentorship in 2018. Her academic interest focuses on improving care of patients with substance use and the chronic diseases associated with addiction and her work has included epidemiologic investigation, investigation of unique delivery care models, examination of safety of addiction pharmacotherapies, and addiction medicine curriculum design, evaluation, and dissemination.